BARINTHUS BIOTHERAPEUT
1.4200
08-November-24 13:43:38
15 minutes delayed
Stocks
-0.0515
-3.50%
Today's range
1.4000 - 1.5100
ISIN
N/A
Source
NASDAQ
-
Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
06 Nov 2024 08:00:01 By Nasdaq GlobeNewswire
-
31 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
01 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
24 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
08 Aug 2024 08:00:01 By Nasdaq GlobeNewswire
-
12 Jun 2024 16:01:00 By Nasdaq GlobeNewswire
-
06 Jun 2024 11:15:00 By Nasdaq GlobeNewswire
-
Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024
22 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
13 May 2024 08:00:01 By Nasdaq GlobeNewswire
-
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
01 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
18 Apr 2024 16:10:00 By Nasdaq GlobeNewswire
-
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
20 Mar 2024 08:15:23 By Nasdaq GlobeNewswire
-
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
05 Jan 2024 16:01:00 By Nasdaq GlobeNewswire
-
New partnership aims to advance vaccine against MERS coronavirus
21 Dec 2023 07:31:16 By Nasdaq GlobeNewswire
-
09 Nov 2023 16:24:43 By Nasdaq GlobeNewswire
-
Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
09 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
06 Nov 2023 09:05:56 By Nasdaq GlobeNewswire
-
13 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
10 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
21 Jun 2023 09:03:54 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >